Policy | December 16, 2025
Pharma overhaul: EMA hails “Once-in-a-Generation” reform
The reform is set to modernise how medicines are developed, authorised, and made available across the EU
The reform is set to modernise how medicines are developed, authorised, and made available across the EU
VLA1601 is a purified and inactivated vaccine specifically designed to protect against the Zika virus
_256_384.jpg)
The transaction is expected to be completed within one month from the signing of the definitive agreements.
The upcoming state-of-the art 400+ bed facility is set to come up at an approximate cost of Rs 500 crore
Approval based on pivotal KOMET Phase III trial demonstrating significant tumour reduction in adults with NF1
Breakthrough expands proactive TB screening from birth to 15 years, ensuring faster and more accurate diagnosis
States exhorted to ensure rational use of cough syrups, particularly among children, as most coughs are self-limiting and do not require pharmacological treatment
Enters the high growth vitamins, minerals and supplements segment for adults, paediatrics, and animal health
Dr. Reddy’s becomes the first pharmaceutical company to receive regulatory approval to launch Linaclotide in India under the brand name Colozo
NATCO holds the first-to-file status for this product and will have 180-day generic drug exclusivity
Subscribe To Our Newsletter & Stay Updated
